4,11-Dihydroxy-2-methyl-5,10-dioxo-N-(piperidin-3-yl)-5,10-dihydro-1H-naphtho[2,3-f]indole-3-carboxamide

ID: ALA4787760

PubChem CID: 162669637

Max Phase: Preclinical

Molecular Formula: C23H21N3O5

Molecular Weight: 419.44

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1[nH]c2c(O)c3c(c(O)c2c1C(=O)NC1CCCNC1)C(=O)c1ccccc1C3=O

Standard InChI:  InChI=1S/C23H21N3O5/c1-10-14(23(31)26-11-5-4-8-24-9-11)15-18(25-10)22(30)17-16(21(15)29)19(27)12-6-2-3-7-13(12)20(17)28/h2-3,6-7,11,24-25,29-30H,4-5,8-9H2,1H3,(H,26,31)

Standard InChI Key:  OELDTGZISVPQCN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   26.3427  -20.1326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3415  -20.9521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0496  -21.3611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0478  -19.7237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7564  -20.1290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7552  -20.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4653  -21.3655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4677  -19.7151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1823  -20.1310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1811  -20.9521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8904  -21.3620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8888  -19.7215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5987  -20.1277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5991  -20.9494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3808  -21.2031    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.8636  -20.5380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3802  -19.8734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4677  -18.8979    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.4648  -22.1827    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.8865  -18.9043    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.8917  -22.1791    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.6323  -19.0961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4316  -18.9258    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.0853  -18.4891    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.6808  -20.5376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6838  -18.1485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4830  -17.9783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1367  -17.5415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3888  -16.7642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7352  -17.2009    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.1881  -16.5939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5  8  1  0
  6  7  1  0
  7 10  1  0
  9  8  1  0
  9 10  2  0
 10 11  1  0
 11 14  2  0
 13 12  2  0
 12  9  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 13  1  0
  8 18  2  0
  7 19  2  0
 12 20  1  0
 11 21  1  0
 17 22  1  0
 22 23  1  0
 22 24  2  0
 16 25  1  0
 23 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
 27 30  1  0
 30 31  1  0
 29 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4787760

    ---

Associated Targets(Human)

CAPAN-1 (772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TERT-RPE1 (415 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 419.44Molecular Weight (Monoisotopic): 419.1481AlogP: 2.14#Rotatable Bonds: 2
Polar Surface Area: 131.52Molecular Species: BASEHBA: 6HBD: 5
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 7.66CX Basic pKa: 9.73CX LogP: 1.95CX LogD: 1.68
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.32Np Likeness Score: 0.03

References

1. Tikhomirov AS,Litvinova VA,Andreeva DV,Tsvetkov VB,Dezhenkova LG,Volodina YL,Kaluzhny DN,Treshalin ID,Schols D,Ramonova AA,Moisenovich MM,Shtil AA,Shchekotikhin AE.  (2020)  Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.,  199  [PMID:32428792] [10.1016/j.ejmech.2020.112294]

Source